Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 6 minute read Pharma Industry News Advanced melanoma immunotherapy enters a new phase as Scancell secures Phase 3 clearance Scancell Holdings Plc, iSCIB1+, advanced melanoma, melanoma immunotherapy, FDA Phase 3 clearance, cancer vaccines, ImmunoBody platform bySoujanya RaviJanuary 29, 2026